LLY Feb 2025 740.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:39PM EDT. Market open.
| Previous Close | 177.20 |
| Open | 177.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 740.00 |
| Expire Date | 2025-02-21 |
| Day's Range | 177.20 - 177.20 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 3 |
ReutersUS Senator Warren calls for scrutiny of Novo Holdings' Catalent deal
U.S. Senator Elizabeth Warren has asked antitrust regulators to closely scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug manufacturer Catalent, saying it may give the pharmaceutical company an unlawful advantage in weight loss and obesity drugs. Novo Holdings, the investment firm that has a controlling interest in Novo Nordisk, signed a $16.5 billion deal to buy Catalent in February to boost supply of Wegovy, Novo's blockbuster GLP-1 weight loss drug.
ZacksNVS or LLY: Which Is the Better Value Stock Right Now?
NVS vs. LLY: Which Stock Is the Better Value Option?
Investor's Business Daily8 Stocks Poised To Report Nvidia-Beating Profit Growth Any Day Now
S&P 500 earnings season is kicking off. And some companies are expected to put up some huge numbers — even bigger than Nvidia
© 2024 Yahoo. All rights reserved.